Outcomes: From the patient perspective, the main outcomes are: 1. Decreased incidence of hip fractures 2. Compliance with intervention 3. Occurrence of complications with the intervention Consumer summary: Hip fractures usually occur in the elderly after suffering a minor fall. Osteoporosis is the main risk factor for hip fractures. Therefore, prevention of hip fractures should naturally focus on prevention of falls and osteoporosis, as well as reducing the risk of fracture resultant from a fall. The two common recommended preventative measures are reviewed. There is good evidence that vitamin D plus calcium supplementation are preventative against hip fractures and some evidence that hip protectors can also be preventative in certain groups of high-risk elders. Although this article does not address other measures, such as bisphosphonates or estrogen replacement therapy, these may be beneficial and should also be considered for patients at risk for osteoporosis. The meta-analysis by Sawka et al reached similar conclusions regarding effectiveness of hip protectors and was later included in the 2010 systematic review by the same author. 8, 9 The two most recent RCTs, with conflicting results, are shown in Table 1 . 10, 11 Lack of adherence to the therapy continues to be a limiting factor, and it is more pronounced outside of nursing home settings. Up to 70% of both community and residential elders are not compliant at follow-up, although the adherence figures are highly variable between studies. The most commonly reported complications with hip protectors are skin irritation and lack of comfort, as well as increased need for nursing care.
The evidence

Conclusion
Hip protectors are helpful to reduce incidence of hip fractures in residential, high-risk patients. Community elders do not benefit from the use of hip protectors. Overall, there is poor adherence to this intervention. Most common complications are skin irritation and discomfort. A high-powered meta-analysis of 29 randomized trials (63,897 participants) examining calcium supplementation found a 12% risk reduction of any type of fracture, including hip fractures. 15 This effect was more pronounced in older patients (70 years), those with lower body weight, and those elders in residential dwelling. The treatment effect was bigger with high-dose calcium supplementation (1200 mg/day) and with high vitamin D doses (800 IU/day). Interestingly, the treatment was shown to be similarly effective with use of calcium alone as with calcium in combination with vitamin D. The protective effect was found to be greater in studies with high compliance. Except for one recent meta-analysis, those that were reviewed concluded that vitamin D plus calcium was superior to vitamin D alone. [15] [16] [17] [18] Table 2 summarizes the systematic reviews and recent meta-analyses of vitamin D alone versus vitamin and calcium supplementation for prevention of hip fractures.
The most commonly reported side effects from the use of vitamin D and calcium are gastrointestinal symptoms, Extensive analyses have been carried out examining the effect of vitamin D, with or without calcium supplementation, in prevention of hip fractures. Although the evidence is not consistent, there seems to be a beneficial effect to high-dose vitamin D supplementation, especially when combined with calcium. The current National Institutes of Health daily intake recommendations are 400 international units (IU) (51-70 years) or 600 IU (70 years) of vitamin D and 1200 mg of calcium (51 years).
The largest systematic review looked at 45 randomized trials in total. This systematic review concluded, on the basis of nine trials (24,749 participants), that vitamin D alone is not likely to be effective in preventing hip fractures. However, based on eight trials (445,658 participants), vitamin D plus calcium (when compared to placebo) demonstrated a significant reduction in the incidence of hip fractures. Similarly, regarding hip protectors, they also concluded that residential-dwelling elders derived the most benefit. 12 The three other systematic reviews concluded that highdose vitamin D was beneficial with greatest benefit derived when supplemented with calcium and in a residential elderly 
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Leytin and Beaudoin renal disease, and hypercalcemia. All of these were modestly but significantly increased in patients receiving treatment versus placebo. According to the systematic review by the Cochrane Collaboration, related vitamin D compounds used do not seem to have advantages when compared to vitamin D, and calcitriol, specifically, may be deleterious through an increase of documented adverse events.
Conclusion
High-dose vitamin D (800 IU) and calcium (1200 mg) in combination are effective at reducing risk of hip fracture,
The practice
• In this article, we addressed two commonly utilized methods of hip fracture prevention. There are many more options available for prevention of osteoporosis and secondarily hip fractures, including bisphosphonates and estrogen modulators. These therapies were beyond the scope of this review; further reading on these topics is recommended below.
Indications for specialist referral
Preventative measures for osteoporosis and hip fractures can be instituted by primary care physicians and do not require specialist referral. especially in institutionalized elderly patients. Adverse events, though rare, can include hypercalcemia and renal disease.
Further reading
Potential pitfalls
• Monitor patients for side effects of treatments, such as skin irritation in the case of hip protectors or hypercalcemia and renal disease in the case of vitamin D and calcium supplementation.
• Monitor and control risk factors for osteoporosis.
• Do not fail to recognize reasons for fracture other than osteoporosis, such as elder abuse or pathologic fracture.
• Investigate cause of frequent falls.
• Recognize the high morbidity and mortality of osteoporotic fractures.
Management
Primary providers should screen for both risk factors for osteoporosis and the disease itself, including bone density screening. Consider vitamin D and calcium supplementation in high-risk individuals. Hip protectors should be considered for residential elders and those at high-risk of hip fracture.
Assessment
Screen for risk factors for osteoporosis (such as tobacco use, low body weight, high alcohol intake, use of steroids, and physical inactivity) and for falls (such as alcohol or substance abuse, underlying medical conditions, poor mobility, vision, cognition, and unsafe environments). Interventions should also be aimed at reduction of these risk factors.
Treatment
• Dose vitamin D at 800 IU per day and calcium at 1200 mg per day.
• Hip protectors may be obtained from numerous commercial vendors. They are available in a variety of styles and sizes, including specific models designed for elders with incontinence.
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